Gut microbiota in breast cancer by menopausal status, Poland
Shotgun metagenomic analysis of 175 fecal samples from 88 newly diagnosed breast cancer patients and 86 controls in Warsaw, stratified by menopausal status, to investigate associations between dysbiosis and cancer development. machine-written summary
153 samples · 153 runs · PL · Adult · 2024 · 3.79 Gbp / sample · cohort Microbial and Metabolic Gut Profiling across Seven
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 1,133 sample values (age, bmi, country, health condition, health condition detail, latitude, location locality, longitude) |
| ✓ Abstract / description | 9 sample values (health condition detail) |
| ✓ Full text | 459 sample values (collection date, location site, sex) · PMC10848918, PMC11311272 |
| ○ Supplementary tables | files read; no table could be matched to the samples |
| ✓ External resources | 153 sample values (antibiotic exposure) · from BugSigDB |
| – User contribution | nothing uploaded yet |
| – Human verified | not yet checked by a person · I checked this project — verify it |
Genera, mean relative abundance over 139 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 153 | 100% | ||||
| country | 153 | 100% | 153 | |||
| health_condition | 144 | 94% | 144 | |||
| subject_id | 0 | 0% | ||||
| age_at_collection_days | 153 | 100% | 153 | |||
| antibiotic_exposure | 153 | 100% | 153 | |||
| collection_date | 153 | 100% | 153 | |||
| detailed_location | 153 | 100% | ||||
| health_condition_detail | 153 | 100% | 144 | 9 | ||
| latitude | 153 | 100% | 153 | |||
| location_locality | 153 | 100% | 153 | |||
| location_site | 153 | 100% | 153 | |||
| longitude | 153 | 100% | 153 | |||
| sex | 153 | 100% | 153 | |||
| bmi | 80 | 52% | 80 |
- Breast cancer but not the menopausal status is associated with small changes of the gut microbiota. 2024 PMID 38327745 PMC10848918 own_data
- Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients. 2024 PMID 39125593 PMC11311272 unsure
Archive description
Possible relationships between gut dysbiosis and breast cancer (BC) development and progression have been previously reported. However, the results of these metagenomics studies are inconsistent. In this study, we performed shotgun metagenomic analyses to compare the gut microbial community between pre- and postmenopausal BC patients and the corresponding controls.</p><p>Fecal samples were collected from 48 and 41 pre- and postmenopausal newly diagnosed BC patients, respectively, and from 51 and 35 pre- and postmenopausal controls, respectively. A total of 12, 64, 158, and 455 phyla, families, genera, and species were identified, respectively. Insignificant differences of the Shannon index and beta-diversity were found at the genus and species levels between pre- and postmenopausal controls the differences concerned only the Chao index at the species level. No differences in alpha-diversity indexes were found between pre- and postmenopausal BC patients, although beta-diversity differed these subgroups at the genus and species levels. Consistently, only the abundance of single taxa differed between pre- and postmenopausal controls and cases, while the abundances of 14 and 23 taxa differed or tended to differ between premenopausal cases and controls, and between postmenopausal cases and controls, respectively. There were similar differences in the distribution of enterotypes. Of 460 bacterial MetaCyc pathways discovered, no pathways differentiated pre- and postmenopausal controls or BC patients, while two and one pathways differentiated cases from controls in the pre- and postmenopausal subgroups, respectively.</p><p>In conclusion, while our findings did not reveal an association of changes in the overall microbiota composition and selected taxa with the menopausal status in cases and controls, they confirmed differences of the gut microbiota between pre- and postmenopausal BC patients and the corresponding controls. However, these differences were less extensive than those described previously.
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of adult and elderly by opus_adjudicated with confidence 0.70. Assay shotgun_dna.
- host run.host_tax_id · “9606”
- body site study.description · “Fecal samples were collected”
- life stage study.description · “pre- and postmenopausal newly diagnosed BC patients”
- life stage sample.attr.host_age · “70 (n=25/153)”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMN37323452 | age_at_collection_days | 17897.2 | R1 | 0.70 | sample.attr.host_age | 49 |
| SAMN37323452 | antibiotic_exposure | no | R2 | 0.60 | external.bugsigdb source | Antibiotics exclusion: 2 months |
| SAMN37323452 | bmi | 31.1 | R1 | 0.90 | sample.attr.host_body_mass_index | 31.1 |
| SAMN37323452 | collection_date | 2018/2021 | R3 | 0.70 | paper.fulltext.methods | Between 2018 and 2021, 174 participants were prospectively enrolled |
| SAMN37323452 | country | PL | R1 | 0.90 | sample.attr.geo_loc_name | Poland:Warsaw |
| SAMN37323452 | health_condition | other_cancer | R1 | 0.80 | biosample_attr | luminal B |
| SAMN37323458 | health_condition | other_cancer | R1 | 0.85 | biosample.attribute:host_disease | TEiple |
| SAMN37703126 | health_condition | ibs | R1 | 0.85 | biosample.attribute:gastrointest_disord | IBS |
| SAMN37323452 | health_condition_detail | luminal B | R1 | 0.90 | sample.attr.host_disease | luminal B |
| SAMN37703134 | health_condition_detail | mixed_case_control: breast cancer patients vs cancer-free controls | R4 | 0.50 | paper.abstract | breast cancer and 86 cancer-free control |
| SAMN37323452 | latitude | 52.1400 | R1 | 0.90 | biosample.attribute:lat_lon | 52.14 N 21 E |
| SAMN37323452 | location_locality | Warszawa | R1 | 0.75 | biosample.attribute:geo_loc_name | Poland:Warsaw |
| SAMN37323452 | location_site | Maria Sklodowska-Curie National Research Institute of Oncology | R3 | 0.70 | paper.fulltext.methods | Maria Sklodowska-Curie National Research Institute of Oncology |
| SAMN37323452 | longitude | 21.0000 | R1 | 0.90 | biosample.attribute:lat_lon | 52.14 N 21 E |
| SAMN37323452 | sex | female | R3 | 0.70 | paper.fulltext.abstract | 88 patients diagnosed with breast cancer and 86 cancer-free control women |
Sequencing
153 runs over 153 samples · mean 4.04 Gbp per run (median 3.79 Gbp, total 617.54 Gbp; 153 runs with a base count) · layout PAIRED 153 · platform ILLUMINA 153 · models Illumina NovaSeq 6000 (153) · 91% of runs with a Sandpiper profile · first public 2024-02-25
Authors (28)
Zeber-Lubecka N first · Kulecka M · Jagiełło-Gruszfeld A · Dąbrowska M · Kluska A · Piątkowska M · Bagińska K · Głowienka M · Surynt P · Tenderenda M · Mikula M · Ostrowski J last · Czarnowski P · Bałabas A · Turkot M · Kruczkowska-Tarantowicz K · Żeber-Lubecka N · Paszkiewicz-Kozik E · Walewski J · Ługowska I · Koseła-Paterczyk H · Rutkowski P · Gawiński C · Wyrwicz L · Borucka M · Krzakowski M · Zając L · Kamiński M
Downloads
PRJNA1001944.csv.gz (5.8 KB) · parquet (78.5 KB) — all 153 samples, every field with route and confidence · PRJNA1001944_determinations.csv.gz (13.3 KB) — 1,754 evidence rows